Mohsen Karimi graduated as a PhD in Medical Genetics at Center of Molecular Medicine (CMM), Karolinska Institutet. He holds an MSc in Molecular and Cellular biology from Tehran University, Iran. He joined the MDS Research Group at HERM in 2009 and is currently working as a molecular biologist.
His main focus is Genetics and Epigenetics profiling of MDS patients. He is an expert in DNA methylation analysis, Chromatin Immuno-precipitation, Next generation sequencing, Pyrosequencing and other molecular biology techniques. Mohsen is involved in high through put mutation analysis of MDS patients using targeted sequencing by Haloplexä technology.